employment due to the branch expansion, as well as the increase of the rents of the existing branches and new branches, despite that the Company had better capacity in manufacturing cost control comparing to
capacity in manufacturing cost control comparing to the previous year. Net Profit In 2017, the Company and its subsidiaries earn the net profit in the amount of THB 484 million, which is increased from the
from 2016 at THB 20,523 million with markets strong throughout the year but particularly after the first quarter on 2017. USD sales were 9% higher in 2017 at USD 635 million up from USD 581m in 2016 as
. Prachnon Termritikulchai who is a Director and CEO of UBIS (Asia) Public Company Limited. 3 Information : Purchase of 6 machineries (Second hand) for manufacturing Size of transaction : It is considered as
%, respectively 3. Product Sales Business Costs of sales consist of costs of manufacturing contracting, as the Company contracts third-party manufacturers to produce the goods for the Company. For the first quarter
came in at 1.47 percent, up from 1.31 percent in the second quarter and within the Bank of Thailand’s target range of 1-4 percent. At the same time, core inflation for the third quarter was 0.78 percent
liabilities 141.13 146.34 154.66 Registered capital 80 80 62 Paid-up capital 80 80 62 Retained earnings (deficit) 19.81 19.89 19.69 Total shareholders’ equity 99.81 99.89 81.69 Total liabilities and
,Amphur Muangsamutsakhon,Samutsakhon 74000,Thailand. Statements of Financial Position (Unit: Million Baht) 2017 2016 2015 Total liabilities 141.13 146.34 154.66 Registered capital 80 80 62 Paid-up capital
., Ltd. (“GWM”), running the business of kidney cleanser and medical supplies manufacturing and distribution, which is increase from the same quarter of the previous years for 32.58 million baht (38.59
loans from packing credit and letter of credit, 52 million increase in trade payables and other payables of buying raw material for manufacturing, and Baht 17 million increase in long-term loans from